Search

Your search keyword '"Gabrielle, Pierre-Henry"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Gabrielle, Pierre-Henry" Remove constraint Author: "Gabrielle, Pierre-Henry" Database Unpaywall Remove constraint Database: Unpaywall
75 results on '"Gabrielle, Pierre-Henry"'

Search Results

1. Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry

2. One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry

3. Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

4. Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina

5. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice

7. Study protocol of OmegaROP-2 prospective study: expression of placental fatty acid receptors in preterm newborns with retinopathy of prematurity

8. A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset of Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment

9. 12-month outcomes of treatment-naïve retinal vein occlusion initially treated with either dexamethasone implants or vascular endothelial growth factor inhibitors: Data from the Fight Retinal Blindness! registry

10. A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset on Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment

14. Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis

15. Update on Retinal Vein Occlusion

17. OmegaROP-2 prospective study: Expression of placental fatty acid receptors in preterm newborns with retinopathy of prematurity

18. Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration

19. Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans

20. Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF

21. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases

23. Topical Antibiotic Prophylaxis and Intravitreal Injections: Impact on the Incidence of Acute Endophthalmitis—A Nationwide Study in France from 2009 to 2018

24. Modification of erythrocyte membrane phospholipid composition in preterm newborns with retinopathy of prematurity: The omegaROP study

31. Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

32. Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries

35. THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA

36. Mobile Telemedicine Screening for Diabetic Retinopathy Using Nonmydriatic Fundus Photographs in Burgundy: 11 Years of Results

37. Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry

38. Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

41. Prediction of Cardiovascular Parameters With Supervised Machine Learning From Singapore “I” Vessel Assessment and OCT-Angiography: A Pilot Study

42. Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

43. Presumed Natural History of Combined Hamartoma of the Retina and Retinal Pigment Epithelium

44. 12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry

45. Cystoid maculopathy is a frequent feature of Cohen syndrome-associated retinopathy

46. Mucosal-associated invariant T cells in Giant Cell Arteritis

47. Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

49. Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

Catalog

Books, media, physical & digital resources